Prosomnus Inc Revenue Growth Rates (OSA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Prosomnus Inc   (NASDAQ: OSA)
 

OSA's Revenue Growth by Quarter and Year

Prosomnus Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OSA Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December -
3rd Quarter September -
2nd Quarter June 9.09
1st Quarter March 7.46
FY 16.55





OSA Revenue second quarter 2024 Y/Y Growth Comment
Prosomnus Inc achieved in the second quarter 2024, above Company average Revenue growth of 34.5% year on year, to $ 9.09 millions.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 52 other companies have achieved higher Revenue growth. While Prosomnus Inc ' s Revenue rise of 34.5% ranks overall at the positon no. 852 in the second quarter 2024.


OSA Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - 61.49 % - -
3rd Quarter September - 29.8 % - -
2nd Quarter June 34.5 % 39.09 % - -
1st Quarter March 47.72 % 35.03 % - -
FY   - 42.6 % - -

Financial Statements
Prosomnus Inc 's second quarter 2024 Revenue $ 9.09 millions OSA's Income Statement
Prosomnus Inc 's second quarter 2023 Revenue $ 6.76 millions Quarterly OSA's Income Statement


OSA Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - 44.07 % 15.8 % -
3rd Quarter September - -3.99 % 2.88 % -
2nd Quarter June 21.88 % 33.86 % 29.95 % -
1st Quarter March -20.21 % -12.78 % - -
FY (Year on Year)   - 42.6 % - -


Back to OSA Growth rate Comparisons >> Back to OSA Growth rate Comparisons >>


Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #53
Healthcare Sector #168
Overall #852

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #53
Healthcare Sector #168
Overall #852
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Prosomnus Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
43.97 % 15.11 % -20.2 %
(Dec 31 2023)  


OSA's II. Quarter Q/Q Revenue Comment
Prosomnus Inc achieved in the II. Quarter 2024 above company average sequential Revenue jump of 21.88%, to $ 9.09 millions, from $7.46 millions in the first quarter.

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Prosomnus Inc 's Revenue growth quarter on quarter, overall rank is 331.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #85
Overall #331
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #14
Healthcare Sector #85
Overall #331
Revenue Q/Q Growth Statistics
High Average Low
43.97 % 15.11 % -20.2 %
(Dec 31 2023)  


OSA's II. Quarter Q/Q Revenue Comment
Prosomnus Inc achieved in the II. Quarter 2024 above company average sequential Revenue jump of 21.88%, to $ 9.09 millions, from $7.46 millions in the first quarter.

Within Medical Equipment & Supplies industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Prosomnus Inc 's Revenue growth quarter on quarter, overall rank is 331.


Prosomnus Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)
Cumulative Revenue 12 Months Ending $ 32.39 $ 30.06 $ 27.65 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 43.28 % 45.2 % 42.59 % - -
Year on Year Revenue Growth Overall Ranking # 359 # 362 # 496 # 496 # 496
Seqeuential Revenue Change (TTM) 7.75 % 8.7 % 14.75 % - -
Seq. Revenue Growth (TTM) Overall Ranking # 1212 # 877 # 0 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2024 period, Prosomnus Inc 's cumulative twelve months Revenue were $ 32 millions, company would post below average annual Revenue growth of 14.75% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Prosomnus Inc 's Revenue growth from the 7.46% growth in Mar 31 2024.

In the Healthcare sector 123 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 359, from total ranking in previous quarter at 362.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 124
Overall # 354

Revenue TTM Y/Y Growth Statistics
High Average Low
45.2 %
 43.69 %
42.59 %
(Mar 31 2024)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 86
Sector # 264
S&P 500 # 1212
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2024 period, Prosomnus Inc 's cumulative twelve months Revenue were $ 32 millions, company would post below average annual Revenue growth of 42.59% year on year, if the fiscal year would end at Jun 30 2024.
A slow-down in the Prosomnus Inc 's Revenue growth from the 7.46% growth in Mar 31 2024.

In the Healthcare sector 123 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 359, from total ranking in previous quarter at 362.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 124
Overall # 354

Revenue TTM Y/Y Growth Statistics
High Average Low
45.2 %
43.69 %
42.59 %
(Mar 31 2024)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 86
Sector # 264
S&P 500 # 1212




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OSA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 30 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2024
Trisalus Life Sciences Inc 59.67%$ 59.670 millions
Ataibeckley Inc 58.72%$ 58.721 millions
Procept Biorobotics Corporation58.54%$ 58.537 millions
Natera Inc 58.13%$ 58.127 millions
Provectus Biopharmaceuticals Inc 57.56%$ 57.556 millions
Ligand Pharmaceuticals Incorporated57.52%$ 57.517 millions
Beone Medicines Ltd 56.07%$ 56.072 millions
Kymera Therapeutics Inc 55.33%$ 55.332 millions
Asensus Surgical Inc 53.72%$ 53.724 millions
Marker Therapeutics inc 53.31%$ 53.311 millions
Sanuwave Health Inc 53.20%$ 53.198 millions
Alimera Sciences Inc52.92%$ 52.919 millions
Hims and Hers Health Inc 52.35%$ 52.354 millions
Xtant Medical Holdings Inc 52.02%$ 52.022 millions
Kiniksa Pharmaceuticals International Plc51.99%$ 51.989 millions
Equillium Inc 51.83%$ 51.830 millions
Aquestive Therapeutics Inc 51.79%$ 51.794 millions
Star Equity Holdings Inc 51.61%$ 51.614 millions
Rhythm Pharmaceuticals Inc 51.28%$ 51.282 millions
Biodesix Inc 50.99%$ 50.986 millions
Mannkind Corporation48.91%$ 48.909 millions
Exscientia Plc48.19%$ 48.195 millions
Aclaris Therapeutics Inc 47.99%$ 47.994 millions
Bespoke Extracts Inc47.76%$ 47.765 millions
Vyne Therapeutics Inc 46.67%$ 46.667 millions
Genedx Holdings Corp 46.47%$ 46.475 millions
Acadia Pharmaceuticals Inc 46.44%$ 46.436 millions
Zai Lab Limited45.95%$ 45.946 millions
Singular Genomics Systems Inc 45.94%$ 45.941 millions
Beyond Air Inc 45.94%$ 45.940 millions


About Prosomnus Inc Revenue Growth Rates (OSA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Prosomnus Inc (CIK 1934064).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-24-010492
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Prosomnus Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.